Blistering rash in a patient with psoriasis

Article Sidebar

PDF (Spanish)
Published: 2006-10-10
DOI: https://doi.org/10.51987/Rev.Hosp.Ital.B.Aires.v26i3.1148

Main Article Content

Daniela Malieni
Servicio de Dermatología. Hospital Italiano de Buenos Aires
Mariana Guzzi Maqueda
Servicio de Dermatología. Hospital Italiano de Buenos Aires
Isabel Hidalgo Parra
Servicio de Dermatología. Hospital Italiano de Buenos Aires
Gastón Galimberti
Servicio de Dermatología. Hospital Italiano de Buenos Aires
Alicia Kowalczuk
Servicio de Dermatología. Hospital Italiano de Buenos Aires
Ricardo Galimberti
Servicio de Dermatología. Hospital Italiano de Buenos Aires

Abstract

.

Downloads

Download data is not yet available.

Article Details

Issue

Vol. 26 No. 3 (2006): Revista del Hospital Italiano de Buenos Aires

Section

Dermatology iconography
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

How to Cite

1.
Malieni D, Guzzi Maqueda M, Hidalgo Parra I, Galimberti G, Kowalczuk A, Galimberti R. Blistering rash in a patient with psoriasis. Rev Hosp Ital B.Aires [Internet]. 2006 Oct. 10 [cited 2026 Jun. 6];26(3):114-6. Available from: https://ojs.hospitalitaliano.org.ar/index.php/revistahi/article/view/1148

References

Yancey KB, Egan CA. Pemphigoid: clinical,histologic, immunopathologic, and therapeuticconsiderations. JAMA 2000;284(3):350-6. DOI: https://doi.org/10.1001/jama.284.3.350

Mutasim DF, Bilic M, Hawayek LH, et al.Immunobullous diseases. J Am Acad Dermatol2005;52(6):1029-43. DOI: https://doi.org/10.1016/j.jaad.2004.11.064

McKenna JK, Leiferman KM. Dermatologicdrug reactions. Immunol Allergy Clin North Am2004;24(3):399-423, vi. DOI: https://doi.org/10.1016/j.iac.2004.03.007

Smith EP, Taylor TB, Meyer LJ, et al. Antigenidentification in drug-induced bullouspemphigoid. J Am Acad Dermatol 1993;29(5Pt 2):879-82. DOI: https://doi.org/10.1016/0190-9622(93)70262-R

Lee JJ, Downham TF 2nd. Furosemide-induced bullous pemphigoid: case report andreview of literature. J Drugs Dermatol 2006;5(6):562-4.

Wojnarowska F, Kirtschig G, Highet AS,et al. Guidelines for the management ofbullous pemphigoid. Br J Dermatol 2002;147(2):214-21. DOI: https://doi.org/10.1046/j.1365-2133.2002.04835.x

Joly P, Roujeau JC, Benichou J, et al. Acomparison of oral and topical corticosteroidsin patients with bullous pemphigoid. N Engl JMed 2002;346(5):321-7. DOI: https://doi.org/10.1056/NEJMoa011592

Ahmed AR. Intravenous immunoglobulintherapy for patients with bullous pemphigoidunresponsive to conventionalimmunosuppressive treatment. J Am AcadDermatol 2001;45(6):825-35 DOI: https://doi.org/10.1067/mjd.2001.116337

Leonardi CL. Efalizumab: an overview. J AmAcad Dermatol 200349(2 Suppl):S98-104 DOI: https://doi.org/10.1016/S0190-9622(03)01141-1

Most read articles by the same author(s)

1 2 > >>